Observational studyBMC medical research methodology2026
Participant recruitment and retention in a longitudinal study: experience from SARS-CoV-2 cohort in Ethiopia.
Observational study in BMC medical research methodology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLongitudinal cohort studies are essential for understanding changes in health over time, yet participant recruitment and retention remain major challenges, especially in low-resource settings. This study describes the strategies, outcomes, and lessons learned from a two-year longitudinal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cohort study conducted in Ethiopia, focusing on engagement among healthcare workers (HCWs) and community members.
methodsThis prospective observational cohort study was nested within a larger longitudinal SARS-CoV-2 project conducted from November 2022 to December 2024. The study enrolled 500 participants, including 350 HCWs and 150 community members, at Jimma Medical Center (JMC). Participants were followed every three months over two years to assess SARS-CoV-2-specific antibody responses. Data collection included venous blood samples, nasopharyngeal swabs (NPS) during symptomatic episodes, and clinical and demographic information. Recruitment used multiple approaches such as phone calls, in-person outreach, and community visits. Retention strategies included flexible scheduling, regular communication, voluntary home visits, and engagement by culturally aware, participant-focused staff.
resultsThe study reached 100% of its target enrollment within 48 days. Over the two-year follow-up, the overall retention rate was 88%, with 82% of participants completing all follow-up visits. High retention was supported by structured contact tracking, regular reminders, culturally sensitive communication, and fair participant compensation. A total of 60 participants were lost to follow-up. Among healthcare workers, the main reasons were relocation (36, 65.5%), health-related issues (6, 10.9%), and unstated reasons (7, 12.7%), with smaller numbers lost due to religious considerations, family influence, or death. In the community group, attrition was mainly due to health-related issues (2, 40%), relocation (1, 20%), religious perspectives (1, 20%), and family influence (1, 20%).
conclusionHigh retention is achievable in longitudinal studies in resource-limited settings when supported by well-planned, context-specific recruitment and retention strategies. This study highlights the value of transparency, participant-centered practices, and operational flexibility, offering practical guidance for future public health research in low- and middle-income countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.